Novo Nordisk's Wegovy Pill Is Capturing 80% of New Oral Obesity Prescriptions. Is NVO Stock a Buy?
Novo Nordisk's GLP-1 pill is performing incredibly well, which is a good sign if you are considering buying the stock.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.